Diana Roettger, PhD, and Olga Kubassova, PhD[email protected]MRIAdvanced imaging offers insight into targeted therapiesMajor breakthroughs are emerging in the development of targeted therapies that use the body's own immune system to attack cancer cells. But traditional methods of measuring the success of drug candidates are slow and expensive. Could advanced imaging help? Diana Roettger, PhD, and Olga Kubassova, PhD, of the Image Analysis Group offer a perspective.February 5, 2019Page 1 of 1Top StoriesWomens ImagingTailoring breast radiotherapy to women's risk leads to successMany women don't have breast cancer recurrence after receiving radiotherapy following initial treatment, a study showed at EBCC15.Radiation Oncology/TherapyAblative RT doubles survival in patients with ‘supermassive’ bile duct tumorsCTEmphysema predicts CAC progression among LCS participantsPractice ManagementResearchers to develop 'patient-centered' imaging assessment toolSponsor ContentModernizing Radiotherapy Workflows
